According to the American Society of Breast Surgeons (ASBS):
"Multi-istitutional trials have demonstrated cryoablation to be a successful option for the resolution of fibroadenomas, without need of surgical excision. The FDA has approved the use of cryoablation as a safe and effective therapy for fibroadenomas. Results of cryoablation have been followed out to 4 years and demonstrate the procedure to be safe, efficacious and durable".
A big number of scientific publications are available related to the use of cryoablation in benign breast lesions (Fibroadenomas).
For more informations, please mail to: info@fibroadenoma.it
NBR - New Biotechnology Research is an association promoting medical and scientific knowledge in medicare, nationwide and internationally. NBR develops research and studies, supports meetings, trials and courses in biomedical field. Cooperate also in evaluation of patents and copyrights for new, emerging solution.